Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Please enquire for more information about 4-Bromobenzaldehyde including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>6-Aminonaphthalene-1-sulfonamide is a monoclonal antibody that binds to the tissue-type plasminogen activator (tPA) receptor and stabilizes the tPA molecule. It has been shown to have a protective effect on tPA from inactivation by serine proteases, which may be useful in life-threatening conditions such as myocardial infarction or stroke. 6-Aminonaphthalene-1-sulfonamide is a potential treatment for thromboembolic disease.</p>

<p>1-(2,6-Dimethylphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione is a pharmaceutical agent that acts as an agonist at the adenosine receptor A2A. It has shown to have a high affinity for the A2A receptor and is selective for the A2A receptor over the other adenosine receptors. 1-(2,6-Dimethylphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione has been used in research to study the role of the A2A adenosine receptor in regulating blood pressure and heart rate.</p>

<p>Versatile small molecule scaffold</p>

<p>Phenothiazine 5-oxide is a potent inhibitor of oxidative reactions that can be used to oxidize phenoxazine. Phenothiazine 5-oxide has been shown to inhibit the oxidation of phenoxazine by sodium hydroxide solution in an electrochemical study. This vibrational, irreversible oxidation reaction was introduced by the introduction of sodium salts, which are potent inhibitors of oxidative reactions. Phenothiazine 5-oxide has been shown to have potent inhibitory activity against cervical cancer cells and shows promise as a chemotherapeutic agent for this type of cancer.</p>

<p>4-Chloro-2-methyl-6-nitroquinoline is an antimicrobial agent that exhibits a broad spectrum of activity against both gram-positive and gram-negative bacteria. It also has antifungal properties. 4-Chloro-2-methyl-6-nitroquinoline inhibits the growth of bacteria by binding to DNA and RNA in the bacterial cell, thereby inhibiting transcription and replication. It also inhibits the synthesis of proteins in fungi, which may be due to its ability to bind to fungal ribosomes and inhibit protein synthesis.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5-(1H-Indol-3-yl)pentanoic acid is a potent and selective serotonin reuptake inhibitor (SSRI). It has been shown to have a high affinity for the serotonin transporter (SERT), with a binding constant of about 5 nM. The compound has been shown to be bifunctional, which means it can inhibit both serotonin and dopamine reuptake. 5-(1H-Indol-3-yl)pentanoic acid is also orally active, so it can be used in vivo as well as in vitro. This drug has been found to have pharmacokinetic properties that are similar to those of fluoxetine and citalopram. Pharmacophore modeling studies have revealed that this drug binds to the SERT by creating hydrogen bonds with amino acids such as serine, threonine, tyrosine and tryptophan.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-(5-Benzyl-6-thioxo-1,3,5-thiadiazinan-3-yl)acetic acid is a hydroxyl group containing fatty acid. It is an implanting agent that has biological properties including skin condition and choroidal neovascularization. Inhibitor compounds have been shown to be effective in preventing the growth of δ opioid receptor agonists in vitro. Sodium citrate can be used as a reconstituted cross linking agent for 2-(5-benzyl-6-thioxo-1,3,5-thiadiazinan-3-yl)acetic acid. Fatty acids are also a cross linking agents for 2-(5-benzyl-6-thioxo-1,3,5 thiadiazinan 3 yl)acetic acid. Furthermore, herpes simplex virus and other viruses are inhibited by 2-(5 benzyl</p>

<p>(2S)-4-Methyl-2-(4-methylbenzenesulfonamido)pentanoic acid is an inhibitor of aminopeptidases, which are enzymes that catalyze the hydrolysis of peptides and proteins. This drug binds to the active site of the enzyme and inhibits its activity. The inhibition is reversible and competitive. It has been shown that this drug has a high inhibitory effect on aminopeptidases in vitro, but the concentration required for inhibition is higher than the therapeutic level. The interaction between (2S)-4-Methyl-2-(4-methylbenzenesulfonamido)pentanoic acid and chloromethylketone has not been investigated yet.<br>(2S)-4-Methyl-2-(4-methylbenzenesulfonamido)pentanoic acid is an inhibitor of pancreatic aminopeptidases A, B, C, D,</p>